Regulation of inner ear development by FGF signals and effectors
FGF 信号和效应器调节内耳发育
基本信息
- 批准号:10097542
- 负责人:
- 金额:$ 45.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-05 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAddressAffectAgeAuditoryBiologicalCandidate Disease GeneCell Differentiation processCell SurvivalCellsCochleaCochlear implant procedureDataDefectDevelopmentDominant-Negative MutationDoxycyclineEpithelialEquilibriumFGF10 geneFGF3 geneFibroblast Growth FactorFibroblast Growth Factor ReceptorsFutureGangliaGenerationsGenesGoalsHealth Care CostsHearingIn VitroIndividualInvestigationKnockout MiceKnowledgeLabyrinthLigandsLightMaintenanceMediatingMesenchymalMessenger RNAMolecularMorphogenesisMorphologyMusNeuronsOtic PlacodesPatternPhenotypeReceptor Protein-Tyrosine KinasesRegulationRoleSensorySignal PathwaySignal TransductionSignaling MoleculeSystemTestingTissuesTransplantationbasecell typecombinatorialconditional knockoutconditional mutantextracellularfibroblast growth factor receptor 2bgene functiongenetic approachgenome-wide analysishearing impairmenthearing restorationin vivoinner ear developmentloss of functionmalformationmolecular markermouse modelmutantnerve supplyneuroblastneurogenesisnovelotoconiaoverexpressionpermanent hearing lossrelating to nervous systemsocialspiral gangliontranscription factor
项目摘要
Morphogenesis of the inner ear epithelium requires coordinated deployment of several signaling pathways and
disruptions cause abnormalities of hearing and/or balance. With the advent of cochlear implantation to treat
hearing loss even in cases of inner ear malformation, it is critical to understand exactly how such malformations
affect the auditory ganglia and innervation. Also, in light of the intense focus on in vitro generation of inner ear
cell types for transplantation and in vivo manipulation of developmental signaling molecules to promote
differentiation of various inner ear cells for hearing restoration, elucidating the roles and regulation of such
signals and their effectors governing otic differentiation and morphogenesis are necessary to advance treatment.
The genes encoding FGF3 and FGF10, ligands that signal through FGFR2b and FGFR1b, are expressed
dynamically throughout otic development in both epithelial and ganglion domains. Studies conducted by the
Mansour Lab of both conventional Fgf3 and Fgf10 conditional knockout mice and those expressing a
doxycycline-inducible ligand trap (dnFGFR2b) that rapidly inhibits signaling through both FGFR1b and
FGFR2b, showed that Fgf3 and Fgf10 are not required in the placode lineage for otocyst formation, but are
required subsequently for otocyst patterning, neuroblast maintenance, epithelial proliferation and both
vestibular and cochlear morphogenesis. Furthermore, the first genome wide analyses of otocyst mRNA revealed
FGFR2b/1b signaling targets that define novel candidates for genes involved in otic morphogenesis and function.
This proposal has two Aims addressing the hypotheses that 1) FGFR2b/1b signaling is required continuously
for both otic neuroblast specification and maintenance, and that at later stages, mesenchymal signaling, as well
as that in the epithelial and ganglion domains, is required for cochlear epithelial differentiation and ganglion
maintenance and 2) FGFR2b/1b downstream target genes mediate some or all of the effects of FGFR2b/1b
signaling on otic morphogenesis and gangliogenesis. To determine the early role of FGFR2b/1b signaling in otic
ganglion formation and its later role in epithelial differentiation and ganglion maintenance, DOX-induced
ubiquitous and CRE-limited expression of dnFGFR2b will be employed and morphology and molecular markers
of otic patterning, proliferation and survival in both tissues will be assessed. To determine the roles of
downstream targets of FGFR2b/1b signaling, two genes encoding transcription factors that are activated by
FGFR2b/1b signaling and one gene encoding a BMP signaling regulator that is repressed by FGFR2b/1b
signaling will be studied. Otic conditional mutants will be generated for each gene, and their morphologic and
functional development will be assessed. In addition, the extent to which the BMP regulator contributes to the
dnFGFR2b phenotypes and the effects of overexpressing the BMP regulator will be assessed.
The results will contribute new knowledge that will facilitate future efforts to manipulate the FGF signaling
system for hearing restoration.
内耳上皮的形态发生需要几个信号通路的协调部署和
精神障碍会导致听力和/或平衡的异常。随着人工耳蜗术的到来而治疗
听力损失即使在内耳畸形的情况下,准确地了解这种畸形是如何发生的也是至关重要的。
影响听觉神经节和神经。此外,鉴于人们对内耳体外培养的高度关注
用于移植的细胞类型和体内操纵发育信号分子以促进
不同类型内耳细胞在听力恢复中的分化及其作用和调控
调控耳部分化和形态发生的信号及其效应器对于推进治疗是必要的。
表达了编码FGF3和FGF10的基因,这些基因是通过FGFR2b和FGFR1b发出信号的配体
在上皮域和神经节域的耳廓发育过程中都有动态变化。进行的研究
常规Fgf3和Fgf10条件性基因敲除小鼠以及表达A基因的小鼠的Mansour实验室
强力霉素诱导的配体陷阱(DnFGFR2b)快速抑制FGFR1b和FGFR1b的信号传导
FGFR2b,表明Fgf3和Fgf10在耳囊形成的胎盘谱系中不是必需的,但
随后需要用于耳囊构型、神经母细胞维持、上皮细胞增殖以及两者
前庭和耳蜗的形态发生。此外,首次全基因组分析耳囊mrna揭示了
FGFR2b/1b信号靶点,定义了涉及耳廓形态发生和功能的基因的新候选基因。
这项提议有两个目的,以解决以下假设:1)FGFR2b/1b信号需要持续
对于耳神经母细胞的指定和维持,以及在后期阶段,间充质信号也是如此
与上皮域和神经节域一样,是耳蜗上皮细胞分化和神经节形成所必需的
2)FGFR2b/1b下游靶基因介导FGFR2b/1b的部分或全部作用
听觉形态发生和神经节形成的信号转导。探讨FGFR2b/1b信号在耳聋早期的作用
神经节形成及其在上皮分化和神经节维持中的作用
将利用dnFGFR2b的普遍存在和Cre限制性表达,以及形态和分子标记
将评估这两个组织中耳廓图案、增殖和存活的情况。确定……的角色
FGFR2b/1b信号的下游靶点,两个编码转录因子的基因被激活
FGFR2b/1b信号和一个编码BMP信号调节因子的基因被FGFR2b/1b抑制
将对信令进行研究。将为每个基因产生特殊的条件突变,并且它们的形态和
将对功能开发进行评估。此外,BMP监管机构在多大程度上有助于
将评估dnFGFR2b的表型和过度表达BMP调节器的影响。
结果将提供新的知识,将促进未来的努力操纵成纤维细胞生长因子信号
听力恢复系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Suzanne L Mansour其他文献
Suzanne L Mansour的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Suzanne L Mansour', 18)}}的其他基金
Regulation of inner ear development by FGF signals and effectors
FGF 信号和效应器调节内耳发育
- 批准号:
10552052 - 财政年份:2021
- 资助金额:
$ 45.96万 - 项目类别:
Regulation of inner ear development by FGF signals and effectors
FGF 信号和效应器调节内耳发育
- 批准号:
10343671 - 财政年份:2021
- 资助金额:
$ 45.96万 - 项目类别:
Regulation of auditory supporting cell differentiation and plasticity
听觉支持细胞分化和可塑性的调节
- 批准号:
9180695 - 财政年份:2015
- 资助金额:
$ 45.96万 - 项目类别:
Regulation of auditory supporting cell differentiation and plasticity
听觉支持细胞分化和可塑性的调节
- 批准号:
9028525 - 财政年份:2015
- 资助金额:
$ 45.96万 - 项目类别:
New mouse models for inducible cell-specific ablation
用于诱导细胞特异性消融的新小鼠模型
- 批准号:
9089993 - 财政年份:2015
- 资助金额:
$ 45.96万 - 项目类别:
2012 Fibroblast Growth Factors in Development & Disease Gordon Research Conferenc
2012 成纤维细胞生长因子的开发
- 批准号:
8313143 - 财政年份:2012
- 资助金额:
$ 45.96万 - 项目类别:
Signals Integrating Cellular Dynamics to Sculpt the Inner Ear (A1)
信号整合细胞动力学来塑造内耳 (A1)
- 批准号:
9037641 - 财政年份:2012
- 资助金额:
$ 45.96万 - 项目类别:
Signals Integrating Cellular Dynamics to Sculpt the Inner Ear (A1)
信号整合细胞动力学来塑造内耳 (A1)
- 批准号:
8294327 - 财政年份:2012
- 资助金额:
$ 45.96万 - 项目类别:
Signals Integrating Cellular Dynamics to Sculpt the Inner Ear (A1)
信号整合细胞动力学来塑造内耳 (A1)
- 批准号:
8824915 - 财政年份:2012
- 资助金额:
$ 45.96万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 45.96万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 45.96万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 45.96万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 45.96万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 45.96万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 45.96万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 45.96万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 45.96万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 45.96万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 45.96万 - 项目类别:
Research Grant